Accelerate Diagnostics, Inc Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2015 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Accelerate Diagnostics, Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2015 to Q3 2024.
  • Accelerate Diagnostics, Inc Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $1.16M, a 36.4% decline year-over-year.
  • Accelerate Diagnostics, Inc Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $4.78M, a 26.1% decline year-over-year.
  • Accelerate Diagnostics, Inc annual Share-based Payment Arrangement, Expense for 2023 was $5.39M, a 49.3% decline from 2022.
  • Accelerate Diagnostics, Inc annual Share-based Payment Arrangement, Expense for 2022 was $10.6M, a 51.8% decline from 2021.
  • Accelerate Diagnostics, Inc annual Share-based Payment Arrangement, Expense for 2021 was $22M, a 33.9% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $4.78M $1.16M -$660K -36.4% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $5.44M $966K -$687K -41.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $6.13M $1.3M +$742K +134% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $5.39M $1.36M -$1.08M -44.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-29
Q3 2023 $6.47M $1.82M +$586K +47.7% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $5.88M $1.65M -$2.32M -58.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $8.2M $555K -$2.42M -81.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 $10.6M $2.45M -$543K -18.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-29
Q3 2022 $11.2M $1.23M -$2.4M -66.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $13.6M $3.97M -$2.62M -39.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $16.2M $2.98M -$5.86M -66.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $22M $2.99M -$1.18M -28.4% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-29
Q3 2021 $23.2M $3.63M -$1.05M -22.4% Jul 1, 2021 Sep 30, 2021 10-Q/A 2023-03-03
Q2 2021 $24.3M $6.59M +$3.17M +92.9% Apr 1, 2021 Jun 30, 2021 10-Q/A 2023-03-03
Q1 2021 $21.1M $8.84M +$4.64M +111% Jan 1, 2021 Mar 31, 2021 10-Q/A 2023-03-03
Q4 2020 $16.5M $4.17M +$964K +30% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-31
Q3 2020 $15.5M $4.68M +$1.55M +49.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $14M $3.42M +$535K +18.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 $13.4M $4.2M +$802K +23.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $12.6M $3.21M +$1.26M +64.9% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-14
Q3 2019 $11.4M $3.13M -$334K -9.64% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $11.7M $2.88M -$528K -15.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $12.2M $3.4M -$2.21M -39.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 $14.4M $1.95M -$1.02M -34.3% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-02
Q3 2018 $15.4M $3.47M -$55K -1.56% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 $15.5M $3.41M -$826K -19.5% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $16.3M $5.6M +$2.39M +74.2% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 $13.9M $2.96M +$779K +35.7% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-28
Q3 2017 $13.2M $3.52M +$850K +31.8% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 $12.3M $4.24M +$2M +89.5% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 $10.3M $3.22M +$1.53M +90.7% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $8.78M $2.18M Oct 1, 2016 Dec 31, 2016 10-K 2019-03-01
Q3 2016 $2.67M +$860K +47.5% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 $2.24M -$293K -11.6% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 $1.69M Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-05
Q3 2015 $1.81M Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 $2.53M Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.